Navigation Links
Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company
Date:3/10/2008

Acquisition Extends Elsevier's Ability to Gather Global Healthcare News and add to it in-Depth Analysis and Commentary That Will Dramatically Increase

Business Value for Customers

PHILADELPHIA, March 10 /PRNewswire-FirstCall/ -- Elsevier, the world's leading publisher of science, technical and health information, announced today that it has acquired Windhover Information Inc., a healthcare business intelligence company that provides analysis and commentary on healthcare business strategy, industry deal making, marketplace trends and medical start-ups.

The acquisition supports Elsevier's e-Health strategy to improve patient healthcare and the business of health in the Pharma business intelligence market. It expands Elsevier's offering of new products and services for Pharma industry professionals by combining innovative technology and industry-leading content to promote faster and better informed planning and management of product portfolios.

"Adding Windhover's expert analysis of the pharmaceutical and medical device industries to our existing regulatory and general business news services and database expands both the depth and breadth of Elsevier's customer offerings," said Brian Nairn, CEO of Elsevier Health Sciences. "Windhover also provides an exciting platform for new products."

Windhover produces authoritative journals such as IN VIVO and the RPM Report, the world's most comprehensive database of healthcare industry transactions (Strategic Transactions Database), and a series of medical-device and biopharmaceutical partnering and strategy conferences. With Windhover, Elsevier will field a team of more than 100 journalists in bureaus covering healthcare developments across the globe.

The acquisition of Windhover is Elsevier's latest in a series of highly synergistic investments in content, workflow tools and e-Health services. Windhover will operate within Elsevier's Pharma Business Intelligence Unit, which includes F-D-C Reports, Inc. (including "The Pink Sheet" and "The Gray Sheet") and Inteleos, a powerful drug development database.

"Elsevier is one of the few companies as dedicated to covering the business of healthcare as Windhover is," said Roger Longman and David Cassack, Managing Partners and co-founders of Windhover. "We're proud to align with The Pink Sheet and other F-D-C Reports products and provide growth opportunities for our staff."

Terms of the acquisition are not being disclosed.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as Science Direct. (http://www.sciencedirect.com/), MDConsult (http://www.mdconsult.com/), Nursing Consult (http://www.nursingconsult.com/) Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Tom Reller

Director of Corp. Relations, Elsevier

+1-212-462-1912

T.Reller@Elsevier.com


'/>"/>
SOURCE Elsevier
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ScienceDirect to Host French-Language Journals from Elsevier Masson
2. Nycomed US Inc. Acquires Bradley Pharmaceuticals, Inc.
3. Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases
4. Setaram Inc. Acquires Hy-Energy LLC
5. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
6. Linc Facility Services Acquires Morse Medical
7. Acrongenomics Acquires Equity Stake in Molecular Vision
8. Inverness Medical Innovations Acquires ParadigmHealth
9. LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer
10. Thermo Fisher Scientific Acquires Leading Chromatography Consumables Provider, La-Pha-Pack
11. Raptor Pharmaceuticals Acquires Orphan Clinical Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... DIEGO , March 29, 2017  Halozyme ... novel oncology and drug-delivery therapies, today announced that ... Food and Drug Administration voted 11 to 0 ... the skin) injection was favorable for patients in ... B-cell lymphoma and chronic lymphocytic leukemia. The FDA ...
(Date:3/29/2017)... ... 2017 , ... Cancer diagnostics and pathology workflow solution provider ... Association of Community Cancer Centers (ACCC) 43rd Annual Meeting, CANCERSCAPE at ... stakeholders from leading national organizations to share insights on how value-based care, drug ...
(Date:3/29/2017)... SAN DIEGO and NEWARK, Del. ... Inc. , a privately-held regenerative medicine company, and ... global materials science company, today announced a collaborative research ... develop novel implantable cell therapy delivery device technologies that ... more than a decade, ViaCyte has been developing innovative ...
(Date:3/29/2017)... DUBLIN , Mar. 29, 2017 ... "Agricultural Biotechnology: Emerging Technologies and Global Markets" report to ... ... (i.e., next generation DNA sequencing, biochips, RNA interference, synthetic biology ... biotech seeds; and biologicals. These technologies and products ...
Breaking Biology Technology:
(Date:3/22/2017)... , March 21, 2017 Optimove ... used by retailers such as 1-800-Flowers and AdoreMe, ... — Product Recommendations and Replenishment. Using Optimove,s machine learning ... personalized product and replenishment recommendations to their customers ... on predictions of customer intent drawn from a ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... ...
(Date:3/7/2017)... March 7, 2017 Brandwatch , the leading social ... The Prince,s Trust to uncover insights to support its reporting, ... The UK,s leading youth charity will be using Brandwatch ... and get a better understanding of the topics and issues that ... ...
Breaking Biology News(10 mins):